tiprankstipranks
Trending News
More News >
Aptevo Therapeutics Inc (APVO)
NASDAQ:APVO
US Market

Aptevo Therapeutics (APVO) Ratios

Compare
569 Followers

Aptevo Therapeutics Ratios

APVO's free cash flow for Q1 2025 was $0.00. For the 2025 fiscal year, APVO's free cash flow was decreased by $ and operating cash flow was $0.00. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
3.15 2.64 3.15 1.51 3.25
Quick Ratio
2.97 2.64 2.97 1.42 2.92
Cash Ratio
2.60 2.34 2.60 1.30 2.75
Solvency Ratio
2.68 -1.33 2.68 -0.47 -0.46
Operating Cash Flow Ratio
-2.41 -1.62 -2.41 -0.62 -2.02
Short-Term Operating Cash Flow Coverage
-10.51 0.00 -10.51 -1.86 -5.86
Net Current Asset Value
$ 11.21M$ 6.45M$ 11.21M$ -2.81M$ 10.31M
Leverage Ratios
Debt-to-Assets Ratio
0.28 0.22 0.28 0.30 0.51
Debt-to-Equity Ratio
0.53 0.44 0.53 13.75 1.65
Debt-to-Capital Ratio
0.35 0.31 0.35 0.93 0.62
Long-Term Debt-to-Capital Ratio
0.07 0.00 0.07 0.75 0.55
Financial Leverage Ratio
1.90 2.03 1.90 46.55 3.23
Debt Service Coverage Ratio
3.96 0.00 3.96 -1.56 -2.72
Interest Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
<0.01 0.00 <0.01 0.01 <0.01
Interest Debt Per Share
82.26 19.41 82.26 156.88 355.72
Net Debt to EBITDA
0.47 0.41 0.47 1.40 0.48
Profitability Margins
Gross Profit Margin
71.07%0.00%71.07%-54.52%-314.30%
EBIT Margin
-919.75%0.00%-919.75%-174.10%-638.06%
EBITDA Margin
-890.82%0.00%-890.82%-164.79%-605.43%
Operating Profit Margin
-919.75%0.00%-919.75%-174.10%-638.06%
Pretax Profit Margin
225.24%0.00%225.24%-239.25%-717.64%
Net Profit Margin
1370.23%0.00%1370.23%-222.20%-428.13%
Continuous Operations Profit Margin
225.24%0.00%225.24%-239.25%-717.64%
Net Income Per EBT
608.34%93.36%608.34%92.88%59.66%
EBT Per EBIT
-24.49%64.58%-24.49%137.42%112.47%
Return on Assets (ROA)
124.71%-70.09%124.71%-48.26%-34.45%
Return on Equity (ROE)
237.39%-142.47%237.39%-2246.13%-111.17%
Return on Capital Employed (ROCE)
-112.28%-163.91%-112.28%-97.97%-70.48%
Return on Invested Capital (ROIC)
-633.37%-163.91%-633.37%-59.31%-37.27%
Return on Tangible Assets
124.71%-70.09%124.71%-48.26%-34.45%
Earnings Yield
9.75%-1.06%9.75%-2.00%-0.40%
Efficiency Ratios
Receivables Turnover
1.25 0.00 1.25 3.35 1.82
Payables Turnover
0.26 4.29 0.26 5.49 3.20
Inventory Turnover
0.57 0.00 0.57 6.16 3.73
Fixed Asset Turnover
0.46 0.00 0.46 3.10 0.78
Asset Turnover
0.09 0.00 0.09 0.22 0.08
Working Capital Turnover Ratio
0.17 0.00 0.17 0.49 0.35
Cash Conversion Cycle
-488.01 -85.00 -488.01 101.50 184.31
Days of Sales Outstanding
293.03 0.00 293.03 108.80 200.67
Days of Inventory Outstanding
636.42 0.00 636.42 59.23 97.79
Days of Payables Outstanding
1.42K 85.00 1.42K 66.53 114.15
Operating Cycle
929.45 0.00 929.45 168.02 298.46
Cash Flow Ratios
Operating Cash Flow Per Share
-181.36 -42.19 -181.36 -203.47 -380.43
Free Cash Flow Per Share
-181.61 -42.19 -181.61 -210.17 -381.57
CapEx Per Share
0.25 0.00 0.25 6.69 1.14
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.03 1.00
Dividend Paid and CapEx Coverage Ratio
-724.90 0.00 -724.90 -30.41 -333.16
Capital Expenditure Coverage Ratio
-724.90 0.00 -724.90 -30.41 -333.16
Operating Cash Flow Coverage Ratio
-2.20 -2.17 -2.20 -1.30 -1.07
Operating Cash Flow to Sales Ratio
-6.75 0.00 -6.75 -1.76 -6.80
Free Cash Flow Yield
-4.81%-0.72%-4.81%-1.64%-0.64%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
10.26 -94.12 10.26 -49.98 -249.25
Price-to-Sales (P/S) Ratio
140.59 0.00 140.59 111.05 1.07K
Price-to-Book (P/B) Ratio
24.36 134.09 24.36 1.12K 277.10
Price-to-Free Cash Flow (P/FCF) Ratio
-20.80 -139.70 -20.80 -60.96 -156.37
Price-to-Operating Cash Flow Ratio
-20.83 -139.70 -20.83 -62.97 -156.84
Price-to-Earnings Growth (PEG) Ratio
-0.08 0.92 -0.08 1.39 2.61
Price-to-Fair Value
24.36 134.09 24.36 1.12K 277.10
Enterprise Value Multiple
-15.31 -57.48 -15.31 -65.99 -175.78
Enterprise Value
424.71M 1.63B 424.71M 1.34B 4.59B
EV to EBITDA
-15.31 -57.48 -15.31 -65.99 -175.78
EV to Sales
136.39 0.00 136.39 108.75 1.06K
EV to Free Cash Flow
-20.18 -138.72 -20.18 -59.70 -155.94
EV to Operating Cash Flow
-20.20 -138.72 -20.20 -61.66 -156.41
Tangible Book Value Per Share
155.06 43.95 155.06 11.41 215.32
Shareholders’ Equity Per Share
155.06 43.95 155.06 11.41 215.32
Tax and Other Ratios
Effective Tax Rate
-5.08 0.00 -5.08 0.07 0.40
Revenue Per Share
26.86 0.00 26.86 115.37 55.91
Net Income Per Share
368.10 -62.62 368.10 -256.35 -239.38
Tax Burden
6.08 0.93 6.08 0.93 0.60
Interest Burden
-0.24 0.65 -0.24 1.37 1.12
Research & Development to Revenue
5.74 0.00 5.74 1.55 4.14
SG&A to Revenue
4.46 0.00 4.46 1.20 3.24
Stock-Based Compensation to Revenue
0.58 0.00 0.58 0.13 0.29
Income Quality
-2.62 0.67 -2.62 0.76 1.65
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis